Role of Consolidative Radiation Therapy After Autologous Hematopoietic Cell Transplantation for the Treatment of Relapsed or Refractory Hodgkin Lymphoma

Hematopoietic Cell ◽

Refractory Hodgkin Lymphoma ◽

Phase I/II Trial of GN-BVC, a Gemcitabine and Vinorelbine-Containing Conditioning Regimen for Autologous Hematopoietic Cell Transplantation in Recurrent and Refractory Hodgkin Lymphoma

10.1016/j.bbmt.2010.02.022 ◽

2010 ◽

Vol 16 (8) ◽

pp. 1145-1154 ◽

Cited By ~ 15

Author(s):

Sally Arai ◽

Renee Letsinger ◽

Ruby M. Wong ◽

Laura J. Johnston ◽

Ginna G. Laport ◽

...

Keyword(s):

Phase I ◽

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Conditioning Regimen ◽

Hematopoietic Cell ◽

Refractory Hodgkin Lymphoma ◽

BEAC (carmustine, etoposide, cytarabine, and cyclophosphamide) in autologous hematopoietic cell transplantation: a safe and effective alternative conditioning regimen for Hodgkin and non-Hodgkin lymphoma

Bone Marrow Transplantation ◽

10.1038/s41409-018-0395-y ◽

2018 ◽

Vol 54 (6) ◽

pp. 921-923

Author(s):

Ioanna Sakellari ◽

Eleni Gavriilaki ◽

Stella Bouziana ◽

Varnavas Constantinou ◽

Despina Mallouri ◽

...

Keyword(s):

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Conditioning Regimen ◽

Hematopoietic Cell ◽

Effective Alternative ◽

Non Hodgkin Lymphoma ◽

Role of Maintenance Therapy after High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation in Aggressive Lymphomas: A Systematic Review

10.1016/j.bbmt.2016.02.007 ◽

2016 ◽

Vol 22 (7) ◽

pp. 1182-1196 ◽

Cited By ~ 5

Author(s):

Josephine A. Taverna ◽

Seongseok Yun ◽

Jayasree Jonnadula ◽

Ahlam Saleh ◽

Irbaz Bin Riaz ◽

...

Keyword(s):

Systematic Review ◽

Maintenance Therapy ◽

Cell Transplantation ◽

High Dose Chemotherapy ◽

Hematopoietic Cell ◽

High Dose ◽

Aggressive Lymphomas ◽

Increased Number of Prior Therapies and/or Use of Mismatched Unrelated Donors Adversely Affect Allogeneic Hematopoietic Cell Transplantation (alloHCT) Outcomes in Relapsed/Refractory Hodgkin Lymphoma (HL)

10.1016/j.bbmt.2012.11.299 ◽

2013 ◽

Vol 19 (2) ◽

pp. S236-S237

Author(s):

Asmita Mishra ◽

Claudio Anasetti ◽

Ernesto Ayala ◽

Hugo Fernandez ◽

Teresa Field ◽

...

Keyword(s):

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Hematopoietic Cell ◽

Allogeneic Hematopoietic Cell Transplantation ◽

Unrelated Donors ◽

Refractory Hodgkin Lymphoma

Role of High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation in Primary Systemic Amyloidosis: A Systematic Review

10.1016/j.bbmt.2009.01.022 ◽

2009 ◽

Vol 15 (8) ◽

pp. 893-902 ◽

Cited By ~ 30

Author(s):

Rahul Mhaskar ◽

Ambuj Kumar ◽

Madhusmita Behera ◽

Mohamed A. Kharfan-Dabaja ◽

Benjamin Djulbegovic

Keyword(s):

Systematic Review ◽

Cell Transplantation ◽

High Dose Chemotherapy ◽

Hematopoietic Cell ◽

Systemic Amyloidosis ◽

High Dose ◽

Risk Factors Predicting Outcomes of Autologous Hematopoietic Cell Transplantation (autoHCT) in Children, Adolescents and Young Adults (CAYA) with Relapsed/Refractory (Rel/Ref) Classical Hodgkin Lymphoma (HL): A CIBMTR Analysis

10.1016/j.bbmt.2014.11.128 ◽

2015 ◽

Vol 21 (2) ◽

pp. S105-S106

Author(s):

Prakash Satwani ◽

Kwang Woo Ahn ◽

Jeanette Carreras ◽

David G. Maloney ◽

Anna Sureda ◽

...

Keyword(s):

Risk Factors ◽

Young Adults ◽

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Hematopoietic Cell ◽

Adolescents And Young Adults ◽

Classical Hodgkin Lymphoma ◽

44 / Outcomes of Primary Effusion Lymphoma: The Role of Autologous Hematopoietic Cell Transplantation

10.26226/morressier.5b3b802db1b87b000eceda58 ◽

2018 ◽

Author(s):

Mirza Abu-Sayeef ◽

Bhagirathbhai Dholaria

Keyword(s):

Cell Transplantation ◽

Primary Effusion Lymphoma ◽

Hematopoietic Cell ◽

Faculty Opinions recommendation of Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.732912577.793581850 ◽

2021 ◽

Author(s):

David Teachey

Keyword(s):

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Phase Ii ◽

Hematopoietic Cell ◽

Classic Hodgkin Lymphoma ◽

Late Effects in Survivors of Hodgkin and Non-Hodgkin Lymphoma Treated with Autologous Hematopoietic Cell Transplantation: A Report from the Bone Marrow Transplant Survivor Study

10.1016/j.bbmt.2007.06.003 ◽

2007 ◽

Vol 13 (10) ◽

pp. 1153-1159 ◽

Cited By ~ 71

Author(s):

Navneet S. Majhail ◽

Kirsten K. Ness ◽

Linda J. Burns ◽

Can-Lan Sun ◽

Andrea Carter ◽

...

Keyword(s):

Bone Marrow ◽

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Bone Marrow Transplant ◽

Late Effects ◽

Marrow Transplant ◽

Hematopoietic Cell ◽

Non Hodgkin Lymphoma ◽

Allogeneic Hematopoietic Cell Transplantation Outcomes After Nivolumab Monotherapy for Relapsed/Refractory Hodgkin Lymphoma (CA209-039 and CheckMate 205)

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2017.07.136 ◽

2017 ◽

Vol 17 ◽

pp. S326-S327 ◽

Cited By ~ 1

Author(s):

Carmelo Carlo-Stella ◽

Graham P. Collins ◽

Philippe Armand ◽

Pier Luigi Zinzani ◽

Jonathon B. Cohen ◽

...

Keyword(s):

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Hematopoietic Cell ◽

Allogeneic Hematopoietic Cell Transplantation ◽

Transplantation Outcomes ◽

Refractory Hodgkin Lymphoma